Figure 4 | Scientific Reports

Figure 4

From: Profiling of cis-Diol-containing Nucleosides and Ribosylated Metabolites by Boronate-affinity Organic-silica Hybrid Monolithic Capillary Liquid Chromatography/Mass Spectrometry

Figure 4

The ribose conjugates that increased or decreased more than 1.5 folds in different cancer types compared to healthy controls.

(A) The identified ribose conjugates whose contents increased more than 1.5 folds in urines of cancer patients compared to healthy controls. (B) The identified ribose conjugates whose contents decreased more than 1.5 folds in urines of cancer patients compared to healthy controls. Each number represents one compound listed in Table 2. And the numbers listed in the overlap region between cycles represent the common compounds that either increased (A) or decreased (B) in different cancer types compared to healthy controls.

Back to article page